Seeing Is Believing
Healthcare - Sector
Aerie Pharmaceuticals's activity chart (see below) currently has 191 price targets and 141 ratings on display.
Analysts average stock forecasts to be materialized ratio is 39.3% with an average time for these price targets to be met of 171.82 days.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 29-Aug-2022. First documented stock forecast 19-Mar-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Dec-2019
$13
3 years 11 months 5 days ago
(29-Aug-2022)
1/6 (16.67%)
$4.7 (56.63%)
176
Buy Since 07-Nov-2019
$20
3 years 11 months 10 days ago
(24-Aug-2022)
0/5 (0%)
$14.21 (245.42%)
Buy Since 09-Jan-2020
$29
3 years 11 months 10 days ago
(24-Aug-2022)
0/2 (0%)
$14.55 (100.69%)
Hold Since 23-Aug-2022
$15.25
$27
3 years 11 months 11 days ago
(23-Aug-2022)
9/13 (69.23%)
$0.09 (0.59%)
174
Buy Since 17-Sep-2015
$14
3 years 11 months 11 days ago
(23-Aug-2022)
7/19 (36.84%)
$7.75 (124.00%)
211
What is AERI (Aerie Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on AERI (Aerie Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on AERI (Aerie Pharmaceuticals)?
Which analyst is the currently most bullish on AERI (Aerie Pharmaceuticals)?
Which analyst is the currently most reserved on AERI (Aerie Pharmaceuticals)?